These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11362905)

  • 1. Variations in viral load still under investigation.
    Smart T
    GMHC Treat Issues; 1995 Sep; 9(9):12-4. PubMed ID: 11362905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
    Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D
    J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the virus.
    Treat Rev; 1995 May; (no 18):5. PubMed ID: 11362593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
    J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA].
    Gariglio R; Taborda MA; Bortolozzi R; McDermott JL; Martini I; Borgognone M; Villanova GV; Varnier OE; Giri AA
    Medicina (B Aires); 2004; 64(5):419-28. PubMed ID: 15560543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr viral load as a marker of lymphoma in AIDS patients.
    Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML
    J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.
    Rouzioux C; Hubert JB; Burgard M; Deveau C; Goujard C; Bary M; Séréni D; Viard JP; Delfraissy JF; Meyer L;
    J Infect Dis; 2005 Jul; 192(1):46-55. PubMed ID: 15942893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New era makes viral-load testing an important tool.
    AIDS Alert; 1996 Aug; 11(8):suppl 1-2. PubMed ID: 11363660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral load out-performs CD4 in disease prediction.
    AIDS Alert; 1996 Apr; 11(4):42-3. PubMed ID: 11363403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.
    Vitone F; Gibellini D; Schiavone P; Re MC
    J Clin Virol; 2005 Jul; 33(3):194-200. PubMed ID: 15911440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral load testing.
    Treat Rev; 1996 Apr; (no 21):8. PubMed ID: 11363399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
    HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantification of T CD4+ lymphocytes and viral RNA in patients with HIV/AIDS].
    Romero-Valdovinos M; Vázquez-Campuzano R; Hirota C; Torres M; González F; Correa D; Flisser A
    Gac Med Mex; 2001; 137(5):501-4. PubMed ID: 11692820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.